Highlights
- Market Cap
- $242.79M
- Enterprise Value
- $250.14M
- EPS (TTM)
- $0.58
- PE Ratio
- 13.09
- PEG Ratio
- 8.57
- Total Revenue (TTM)
- $183.80M
- Gross Profit (TTM)
- $61.75M
- EBITDA (TTM)
- $24.85M
- Year Range
- $7.36 - $64.00
- ROA (TTM)
- 9.73%
- ROE (TTM)
- 11.25%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Meihua International Medical Technologies Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Meihua International Medical Technologies Co Ltd (MHUA) has returned 0.00% so far this year and -77.31% over the past 12 months.
Meihua International Medical Technologies Co Ltd
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- -78.97%
- 1Y
- -77.31%
- 3Y*
- -77.28%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Feb 16, 2022, MHUA's average daily return is -0.18%, while the average monthly return is -3.52%.
Historically, 34% of months were positive and 66% were negative. The best month was Feb 2023 with a return of +128.2%, while the worst month was Mar 2023 at -80.9%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 5 months.
On a daily basis, MHUA closed higher 44% of trading days. The best single day was Feb 21, 2023 with a return of +49.9%, while the worst single day was Dec 8, 2025 at -45.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.00% | 0.00% | 0.00% | ||||||||||
| 2025 | -7.74% | 3.02% | 2.26% | -18.01% | 65.47% | -12.10% | -5.20% | 10.73% | -13.81% | -35.59% | -49.03% | -35.94% | -77.95% |
| 2024 | -32.43% | -29.52% | 4.71% | -6.64% | -4.95% | 30.09% | 19.73% | -10.37% | 11.57% | -33.33% | -22.35% | -34.64% | -76.68% |
| 2023 | 79.83% | 128.21% | -80.90% | -44.53% | -23.33% | 3.26% | -5.09% | 3.51% | -36.79% | -1.44% | 4.32% | -18.68% | -82.13% |
| 2022 | -36.38% | 14.36% | -11.70% | -30.72% | -7.83% | -10.57% | -19.83% | 57.89% | 28.33% | 74.42% | -38.35% | -35.91% |
Benchmark Metrics
Meihua International Medical Technologies Co Ltd has an annualized alpha of -42.12%, beta of 0.86, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since February 17, 2022.
- This stock participated in 195.45% of S&P 500 Index downside but only -129.19% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -42.12%
- Beta
- 0.86
- R²
- 0.01
- Upside Capture
- -129.19%
- Downside Capture
- 195.45%
Return for Risk
Risk / Return Rank
MHUA ranks 8 for risk / return — in the bottom 8% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Meihua International Medical Technologies Co Ltd (MHUA) and compare them to a chosen benchmark (S&P 500 Index).
| MHUA | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.71 | 0.90 | -1.60 |
Sortino ratioReturn per unit of downside risk | -1.10 | 1.39 | -2.48 |
Omega ratioGain probability vs. loss probability | 0.82 | 1.21 | -0.39 |
Calmar ratioReturn relative to maximum drawdown | -0.88 | 1.40 | -2.28 |
Martin ratioReturn relative to average drawdown | -1.65 | 6.61 | -8.26 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore MHUA risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Meihua International Medical Technologies Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Meihua International Medical Technologies Co Ltd was 99.80%, occurring on Dec 8, 2025. The portfolio has not yet recovered.
The current Meihua International Medical Technologies Co Ltd drawdown is 99.80%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.8% | Feb 22, 2023 | 702 | Dec 8, 2025 | — | — | — |
| -79.87% | Feb 17, 2022 | 109 | Jul 26, 2022 | 88 | Nov 29, 2022 | 197 |
| -47.44% | Nov 30, 2022 | 21 | Dec 29, 2022 | 21 | Jan 31, 2023 | 42 |
| -19.75% | Feb 10, 2023 | 1 | Feb 10, 2023 | 4 | Feb 16, 2023 | 5 |
| -5.01% | Feb 2, 2023 | 3 | Feb 6, 2023 | 1 | Feb 7, 2023 | 4 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Meihua International Medical Technologies Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Meihua International Medical Technologies Co Ltd is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for MHUA, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, MHUA has a P/E ratio of 13.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for MHUA compared to other companies in the Medical Instruments & Supplies industry. MHUA currently has a PEG ratio of 8.6. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MHUA relative to other companies in the Medical Instruments & Supplies industry. Currently, MHUA has a P/S ratio of 1.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for MHUA in comparison with other companies in the Medical Instruments & Supplies industry. Currently, MHUA has a P/B value of 1.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |